当前位置:首页 - 行情中心 - 睿智医药(300149) - 财务分析

睿智医药

(300149)

  

流通市值:47.55亿  总市值:49.90亿
流通股本:4.75亿   总股本:4.98亿

睿智医药(300149)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2026年第一季度实现净利润-0.18亿元,每股收益-0.04元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2026年第一季度最新股东权益131144.65万元,未分配利润-68531.60万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2026年第一季度最新总资产204004.11万元,负债72859.46万元。

利润表
报告期2026-03-312025-12-312025-09-302025-06-30
营业总收入266,689,812.561,134,719,476.3816,848,135.12533,797,976.84
营业总成本289,479,241.791,116,539,022.01815,922,997.79513,553,112.14
其他经营收益
营业利润-23,316,598.4623,087,141.6813,928,933.1231,671,672.69
利润总额-23,438,903.7616,012,032.7814,749,487.432,110,947.08
净利润-18,027,945.9513,553,054.337,162,056.6525,345,366.23
每股收益
其他综合收益-9,785,903.53-5,336,908.18-2,279,583.73-374,978.77
综合收益总额-27,813,849.488,216,146.154,882,472.9224,970,387.46
资产负债表
报告期2026-03-312025-12-312025-09-302025-06-30
流动资产:
流动资产合计788,863,348.75765,017,393.1697,464,429.81680,417,089.77
非流动资产:
非流动资产合计1,251,177,709.191,267,927,806.111,291,989,135.871,300,169,768.43
资产总计2,040,041,057.942,032,945,199.211,989,453,565.681,980,586,858.2
流动负债:
流动负债合计369,610,581.48355,445,229.86332,734,971.55343,418,505.78
非流动负债:
非流动负债合计358,984,006.96377,140,438.62378,889,306.57374,888,002.33
负债合计728,594,588.44732,585,668.48711,624,278.12718,306,508.11
所有者权益(或股东权益):
归属于母公司股东权益合计1,282,151,610.681,276,017,116.031,253,557,011.181,238,115,581.3
股东权益合计1,311,446,469.51,300,359,530.731,277,829,287.561,262,280,350.09
负债和股东权益合计2,040,041,057.942,032,945,199.211,989,453,565.681,980,586,858.2
现金流量表
报告期2026-03-312025-12-312025-09-302025-06-30
经营活动产生的现金流量:
经营活动现金流入小计283,274,396.551,161,337,279.24865,049,401.47583,016,858.73
经营活动现金流出小计241,993,532.27970,838,470.92744,814,231.35517,681,774.34
经营活动产生的现金流量净额41,280,864.28190,498,808.32120,235,170.1265,335,084.39
投资活动产生的现金流量:
投资活动现金流入小计17,715,187.23127,194,956.3479,401,101.0861,612,910.81
投资活动现金流出小计29,666,177.81197,099,661.45133,887,076.1289,818,772.95
投资活动产生的现金流量净额-11,950,990.58-69,904,705.11-54,485,975.04-28,205,862.14
筹资活动产生的现金流量:
筹资活动现金流入小计4,923,921.5787,300,00040,300,00036,300,000
筹资活动现金流出小计6,484,746.39167,011,241.28105,352,877.9786,109,221.34
筹资活动产生的现金流量净额-1,560,824.82-79,711,241.28-65,052,877.97-49,809,221.34
汇率变动对现金及现金等价物的影响-8,049,152.711,149,651.1-1,754,786.44633,349.4
现金及现金等价物净增加额19,719,896.1742,032,513.03-1,058,469.33-12,046,649.69
期末现金及现金等价物余额425,201,281405,481,384.83362,390,402.47351,402,222.11
补充资料:
现金及现金等价物的净增加额-42,032,513.03--12,046,649.69
TOP↑